"Influenza Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains.
| Descriptor ID |
D007252
|
| MeSH Number(s) |
D20.215.894.899.302
|
| Concept/Terms |
Influenza Vaccines- Influenza Vaccines
- Influenza Vaccine
- Vaccine, Influenza
- Flu Vaccines
- Influenzavirus Vaccines
- Influenza Virus Vaccines
- Influenza Virus Vaccine
- Vaccine, Influenza Virus
- Virus Vaccine, Influenza
|
Below are MeSH descriptors whose meaning is more general than "Influenza Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Influenza Vaccines".
This graph shows the total number of publications written about "Influenza Vaccines" by people in this website by year, and whether "Influenza Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 0 | 4 |
| 1996 | 4 | 0 | 4 |
| 1997 | 2 | 2 | 4 |
| 1998 | 2 | 1 | 3 |
| 2000 | 3 | 2 | 5 |
| 2001 | 1 | 1 | 2 |
| 2002 | 5 | 1 | 6 |
| 2003 | 1 | 0 | 1 |
| 2004 | 8 | 1 | 9 |
| 2005 | 5 | 0 | 5 |
| 2006 | 6 | 0 | 6 |
| 2007 | 8 | 0 | 8 |
| 2008 | 7 | 0 | 7 |
| 2009 | 10 | 2 | 12 |
| 2010 | 7 | 1 | 8 |
| 2011 | 7 | 0 | 7 |
| 2012 | 9 | 3 | 12 |
| 2013 | 9 | 2 | 11 |
| 2014 | 6 | 3 | 9 |
| 2015 | 13 | 1 | 14 |
| 2016 | 13 | 3 | 16 |
| 2017 | 10 | 4 | 14 |
| 2018 | 11 | 1 | 12 |
| 2019 | 15 | 5 | 20 |
| 2020 | 14 | 1 | 15 |
| 2021 | 28 | 1 | 29 |
| 2022 | 20 | 0 | 20 |
| 2023 | 15 | 0 | 15 |
| 2024 | 22 | 2 | 24 |
| 2025 | 10 | 0 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza Vaccines" by people in Profiles.
-
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study. Clin Infect Dis. 2025 Apr 30; 80(4):893-900.
-
Coadministration of RSV + influenza or COVID-19 vaccines was noninferior to separate administration for immune responses in adults aged =50 y. Ann Intern Med. 2025 Apr; 178(4):JC41.
-
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone? or Flublok?) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45?years of age. Vaccine. 2025 Apr 30; 54:126991.
-
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27; 74(6):83-90.
-
Structural mapping of polyclonal IgG responses to HA after influenza virus vaccination or infection. mBio. 2025 Mar 12; 16(3):e0203024.
-
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season. J Infect Dis. 2025 Feb 04; 231(1):e123-e131.
-
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022. Vaccine. 2025 Feb 27; 48:126806.
-
Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015-2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Hum Vaccin Immunother. 2025 Dec; 21(1):2457205.
-
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59?. Vaccine. 2025 Feb 15; 47:126702.
-
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens. Vaccine. 2025 Feb 15; 47:126689.